{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:37:28Z","timestamp":1791855448850,"version":"4.3.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>From the advancement of treatment of pediatric cancer diagnosis, the five-year survival rate has increased significantly. However, the adverse consequence of improved survival rate is the second malignant neoplasm. Although previous studies provided information on the incidence and risk of SMN in long term survivors of childhood cancer, there is still scarce information known for short term (&amp;lt; 5 years) prognosis. This study aims to assess the incidence, characteristics, management, and outcome of children who develop SMN malignancies within 5 years of diagnosis of their initial cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>This is a retrospective cohort study of early Second Malignant Neoplasms (SMN) in pediatric oncology patients. The Cancer in Young People \u2013 Canada (CYP-C) national pediatric cancer registry was used and reviewed pediatric patients diagnosed with their first cancer from 2000-2015.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 20,272 pediatric patients with a diagnosis of a first malignancy were analyzed. Of them, 0.7% were diagnosed with a SMN within the first 5 years following their first cancer diagnosis. Development of a SMN impacted survival, shown by an inferior survival rate in the SMN cohort (79.1%) after three years compared to that of the non-SMN cohort (89.7%). Several possible risk factors have been identified in the study including the use of epipodophyllotoxins, exposure to radiation, and hematopoietic stem cell 169 transplant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This is the first national study assessing the incidence, 170 characteristics, risk factors and outcome of early SMN in Canadian children 171 from age 0-15 from 2000-2015.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1376652","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:47:54Z","timestamp":1711601274000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Christina","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Subburaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskiran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Laverty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Pole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Pelland-Marcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Israels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thai-Hoa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Oberoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Renzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"B1","unstructured":"Cancer in young people in Canada data tool. 2020 editionPublic Health Infobase2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207243","article-title":"Second Malignant neoplasms after childhood cancer: A nationwide population-based study in Korea","volume":"13","author":"Ju","year":"2018","journal-title":"PloS One"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0465","article-title":"Second primary Malignant neoplasms and survival in adolescent and young adult cancer survivors","volume":"3","author":"Keegan","year":"2017","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in late mortality among 5-year survivors of childhood cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2017.0693","article-title":"Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015","volume":"317","author":"Turcotte","year":"2017","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24445","article-title":"A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"60","author":"Kremer","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4351","article-title":"Long term cause specific mortality among 34\u2009489 five year survivors of childhood cancer in Great Britain: population based cohort study","volume":"354","author":"Fidler","year":"2016","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000153","article-title":"Cancer survivorship and models of survivorship care: A review","volume":"38","author":"Miller","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-0360","article-title":"Subsequent Malignant neoplasms in a population-based cohort of pediatric cancer patients: A focus on the first 5 years","volume":"24","author":"Pole","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00562","article-title":"Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the international guideline harmonization group","volume":"38","author":"Mulder","year":"2020","journal-title":"J Clin Oncol"},{"key":"B14","volume-title":"The children\u2019s oncology group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (COG LTFU guidelines)","year":"2023"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq238","article-title":"Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study","volume":"102","author":"Friedman","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22827","article-title":"New Malignancies following childhood cancer in the United States, 1973-2002","volume":"121","author":"Inskip","year":"2007","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/children6120130","article-title":"Large population analysis of secondary cancers in pediatric leukemia survivors","volume":"6","author":"Yavvari","year":"2019","journal-title":"Children (Basel)"},{"key":"B18","unstructured":"ICCC recode ICD-O-3\/WHO 2008 table - SEER recodes. Surveillance, epidemiology, and end results programNational Cancer Institute2008"},{"key":"B19","unstructured":"Health indicators 2013: definitions, data sources and rationale2013"},{"key":"B20","unstructured":"Postal code conversion file (PCCF), reference guide. Statistics Canada2011"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.10.002","article-title":"Risk of a second cancer in Canadians diagnosed with a first cancer in childhood or adolescence","volume":"16","author":"Zakaria","year":"2019","journal-title":"EClinicalMedicine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.035","article-title":"Second Malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study","volume":"84","author":"Zong","year":"2017","journal-title":"Eur J Cancer"},{"key":"B23","volume-title":"Statistics Canada\u2019s guidance on rounding","year":"2006"},{"key":"B24","unstructured":"A decade of progress in cancer care, and what\u2019s next\n            GrishamJ\n          Memorial Sloan Kettering Cancer Center2020"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of cancer pharmacological treatments at the turn of the third millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Front Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B27","year":"2012"},{"key":"B28","article-title":"Analysing survival data from clinical trials and observational studies","volume":"41","author":"Marubini","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1002\/9780470258019","volume-title":"Applied survival analysis","author":"Hosmer","year":"2008"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2014.11.009","article-title":"PSHREG: A SAS macro for proportional and nonproportional subdistribution hazards regression","volume":"118","author":"Kohl","year":"2015","journal-title":"Comput Methods Prog Biomed"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907203210302","article-title":"Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia","volume":"321","author":"Pui","year":"1989","journal-title":"New Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"New Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2020_200214N131","article-title":"Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood","volume":"67","author":"Keslova","year":"2020","journal-title":"Neoplasma"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00129","article-title":"Chemotherapy and risk of subsequent Malignant neoplasms in the childhood cancer survivor study cohort","volume":"37","author":"Turcotte","year":"2019","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90094-1","article-title":"Second Malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience","volume":"17","author":"Cooper","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.774348","article-title":"Total body irradiation in haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia: review of the literature and future directions","volume":"9","author":"Hoeben","year":"2021","journal-title":"Front Pediatr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6902","article-title":"Long-term risk of subsequent Malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy","volume":"35","author":"Teepen","year":"2017","journal-title":"J Clin Oncol"},{"key":"B39","unstructured":"Second cancers - landmark studies. National cancer institute surveillance, epidemiology, and end results program2003"},{"key":"B40","unstructured":"About the SEER registries. National cancer institute, surveillance, epidemiology, and end results program"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33817","article-title":"Impact of era of diagnosis on cause-specific late mortality among 77\u2009423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium","volume":"150","author":"Byrne","year":"2022","journal-title":"Int J Cancer"}],"updated-by":[{"DOI":"10.3389\/fonc.2024.1418512","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1376652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T08:49:07Z","timestamp":1715330947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1376652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":41,"alternative-id":["10.3389\/fonc.2024.1376652"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1376652","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fonc.2024.1418512","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"article-number":"1376652"}}